The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital

P Pradat1, C Francannet, J A Harris

  • 1Tornblad Institute, Biskopsgatan 7, University of Lund, Lund, Sweden.

Pediatric Cardiology
|March 13, 2003
PubMed

Insights

This study analyzed congenital heart defects in infants across three registries, finding similar overall rates but significant variations in specific defect prevalence and demographic associations. Understanding these differences is key for targeted interventions.

Area of Science:

  • Pediatric Cardiology
  • Epidemiology
  • Public Health

Background:

  • Congenital cardiovascular defects (CCDs) are a significant concern in infant health.
  • Understanding the prevalence and demographic associations of CCDs is crucial for public health initiatives.

Purpose of the Study:

  • To analyze the prevalence of complex and noncomplex cardiac malformations.
  • To investigate demographic variables in relation to specific congenital heart defects.

Main Methods:

  • Pooled data from three large birth defect registries (California, Sweden, France).
  • Included 12,932 infants with congenital heart defects out of 4.4 million live births and stillbirths.
  • Data collection involved registry reporting and medical record review, acknowledging differing ascertainment methods.

Main Results:

  • Overall severe defect rates were similar (1.43 per 1,000), but specific defect rates varied.
  • Significant differences in epidemiological characteristics and sex ratios were observed for specific defects (e.g., hypoplastic left heart syndrome, tetralogy of Fallot).
  • Some defects showed similar epidemiological patterns, while others, like combined septal defects, behaved differently.

Conclusions:

  • While overall severe congenital heart defect rates are consistent, specific defect prevalence and associated demographic factors show significant international variation.
  • These findings highlight the need for tailored epidemiological approaches to congenital heart defect research and intervention.
  • Further research is warranted to elucidate the complex interplay between genetics, environment, and demographics in congenital heart defect etiology.

Related Concept Videos

Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...